Profil
Keith S.
Ehrlich worked as an Auditor at Coopers & Lybrand LLP from 1980 to 1991.
He then worked as Treasurer & Finance Director at Vertex Pharmaceuticals, Inc. from 1991 to 1993, followed by CFO, Treasurer, VP-Finance & Administration at OraVax, Inc. from 1993 to 1998.
He then worked as CFO, Treasurer, SVP-Finance & Administration at Dyax Corp.
in 1998 and CFO, Vice President-Finance & Administration at Argentys Corp.
from 1999 to 2003.
He joined Synta Pharmaceuticals Corp.
in 2004 and worked as CFO, Vice President-Finance & Administration until 2014.
From 2015 to 2017, he worked as CFO & Principal Accounting Officer at AVEO Pharmaceuticals, Inc. Mr. Ehrlich received his undergraduate degree from Drew University and his MBA from Rutgers State University of New Jersey.
Anciens postes connus de Keith S. Ehrlich
| Sociétés | Poste | Fin |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/06/2017 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Directeur Financier/CFO | 08/12/2014 |
Argentys Corp.
Argentys Corp. Packaged SoftwareTechnology Services Develops and provides scientific computational software solutions | Directeur Financier/CFO | 01/04/2003 |
| DYAX CORP. | Directeur Financier/CFO | 01/07/1999 |
OraVax, Inc.
OraVax, Inc. BiotechnologyHealth Technology Develops oral vaccines and non injected antibody products | Directeur Financier/CFO | 01/01/1998 |
Formation de Keith S. Ehrlich
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Drew University
Drew University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
OraVax, Inc.
OraVax, Inc. BiotechnologyHealth Technology Develops oral vaccines and non injected antibody products | Health Technology |
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
Coopers & Lybrand LLP
Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Argentys Corp.
Argentys Corp. Packaged SoftwareTechnology Services Develops and provides scientific computational software solutions | Technology Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
















